Fiji vs Lebanon: Statin use vs. average non-HDL cholesterol levels
Fiji
3.8
in 2018
Lebanon
3.9
in 2018
Fiji rank
6th
Lebanon rank
4th
Statin use vs. average non-HDL cholesterol levels over time
- Fiji
- Lebanon
How they compare
Lebanon currently reports 3.9 against 3.8 in Fiji, a difference of 0.1.
Across all 39 years both countries report, Lebanon has been ahead every year.
Fiji ranks 6th and Lebanon ranks 4th of 191 countries.
Lebanon has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Fiji | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.83 | 4.06 | 0.23 | Lebanon |
| 1990s | 3.95 | 4.1 | 0.15 | Lebanon |
| 2000s | 3.95 | 4 | 0.05 | Lebanon |
| 2010s | 3.84 | 3.9 | 0.0556 | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Fiji or Lebanon?
- Lebanon, at 3.9 against 3.8 in Fiji as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Fiji and Lebanon?
- 0.1, with Lebanon ahead.
- How many years of comparable data are there for Fiji and Lebanon?
- 39 years are reported by both, from 1980 to 2018.
- How do Fiji and Lebanon rank globally for statin use vs. average non-hdl cholesterol levels?
- Fiji ranks 6th and Lebanon ranks 4th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.